SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-001659
Filing Date
2023-11-07
Accepted
2023-11-07 06:30:28
Documents
13
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AGENUS INC. 8-K a53764435.htm   iXBRL 8-K 27557
2 EXHIBIT 99.1 a53764435ex99_1.htm EX-99.1 87839
  Complete submission text file 0001157523-23-001659.txt   261713

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agen-20231107.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20231107_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20231107_pre.xml EX-101.PRE 16048
7 EXTRACTED XBRL INSTANCE DOCUMENT a53764435_htm.xml XML 4046
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 231381436
SIC: 2836 Biological Products, (No Diagnostic Substances)